The FDA granted accelerated approval to Keytruda, an adult and pediatric treatment for unresectable or metastatic solid tumors identified as having a biomarker.
GI & Endoscopy
AmSurg, Evolution Health and other industry-leading organizations gathered at a GI Research Summit, March 2 at Envision Healthcare's Nashville, Tenn. headquarters, to discuss how to study and leverage GIQuIC data in pursuit of Healthcare Quadruple Aim.
Here are four GI companies in the headlines from the past week.
Benjamin Schaus, DO, is a gastroenterologist at Buffalo (N.Y.) Gastroenterology Associates.
The Minnesota Safety Council recognized Takeda Pharmaceuticals for excellence in workplace safety.
Advertisement
A study published in the Annals of Internal Medicine examined interval colorectal cancer risks in minorities.
United Way of Northern New Jersey recognized Allergan for its positive impact in New Jersey over the last year, NJBiz.com reports.
A National Academy of Sciences, Engineering and Medicine report offers recommendations to eliminate approximately 90,000 hepatitis B and C-related deaths by 2030, Gastroenterology and Endoscopy News reports.
Mark Young, MD, is a gastroenterologist at Johnson City-based Gastrointestinal Associates of Northeast Tennessee.
Gastroenterologist Marvin M. Schuster, MD, 87, died on May 12 after a battle with heart disease, The Baltimore Sun reports.